Chronic myeloid leukaemia is a haemopoietic stem cell disorder, the hallmark of which is the expression of the Bcr-Abl Protein Tyrosine Kinase (PTK). We have previously reported that activation of a temperature sensitive Bcr-Abl PTK in the multipotent haemopoietic cell line FDCP-Mix for short periods resulted in subtle changes including, a transient suppression of apoptosis and no inhibition of dierentiation. In contrast, activation of the Bcr-Abl PTK for 12 weeks results in cells that display a delay in dierentiation at the early granulocyte stage. Flow cytometric analysis also indicates that the expression of cell surface dierentiation markers and nuclear morphology are uncoupled. Furthermore, a signi®cant number of the mature neutrophils display abnormal morphological features. Prolonged exposure to Bcr-Abl PTK results in interleukin-3 independent growth and decreased p53 protein levels. FDCP-Mix cells expressing a dominant negative p53 and p53 null FDCP-Mix cells demonstrate that the reduction in p53 is causally related to the delay in development. Returning the cells to the restrictive temperature restores the p53 protein levels, the growth factor dependence and largely relieves the eects on development. We conclude that prolonged Bcr-Abl PTK activity within multipotent cells results in a reduction of p53 that drives a delayed and abnormal dierentiation. Oncogene (2000) 19, 5487 ± 5497.
Introduction
Chronic myeloid leukaemia (CML) is a clonal disorder of pluripotent haemopoietic cells characterized by the presence of the Philadelphia chromosome (Ph + ), the result of a reciprocal translocation between chromosome 9 and 22 (for a review see Gotoh and Broxmeyer, 1997 ). The 9:22 translocation fuses the Bcr gene with the Abl gene resulting in the expression of a chimeric protein, Bcr-Abl, that has an essential role in the molecular pathology of CML (Daley et al., 1990; Griths et al., 1992; Heisterkamp et al., 1990; Kelliher et al., 1990) . The Bcr-Abl protein contains several functional domains including, most importantly, a constitutively activated form of the c-abl protein tyrosine kinase (PTK) (Konopka et al., 1984; Lugo et al., 1990) .
CML is a progressive disease with an initial chronic phase in which there is a marked expansion in the late myeloid cell population (reviewed by Strife, 1993 and Verfaille, 1998) . CML progenitor cells possess only a subtle defect in maturation, whilst retaining their requirements for bone marrow stromal cells or cytokines to survive and proliferate (Gishizky and Witte, 1992) . In the course of the disease, this stage is followed by an accelerated phase that can include myelodysplastic features, hyposegmented neutrophils and basophilia. The blast crisis is the most severe manifestation of the disease in which dierentiation is apparently blocked.
Although Bcr-Abl expression plays an initiating role in the pathogenesis of CML, the transformation to blast crisis appears to arise as a consequence of additional events Foti et al., 1991) that are as yet poorly de®ned. Alterations in p53 expression are, however, implicated in disease progression. Whilst structural alterations of p53 are very rare in the chronic phase of CML, they are detected in 25 ± 30% of CML blast crisis cases (Ahuja et al., 1989; Mashal et al., 1990; Prokocimer and Rotter, 1994) . Although the majority of studies concentrate on p53 mutations, several reports have implicated a mere reduction in wild type (wt) p53 gene dosage as a factor of key importance for the development of the accelerated phase Nakai et al., 1992; Rovira et al., 1995) . reported that the loss of a wtp53 allele preceded any p53 mutation and that the hemizygous wtp53 expression conferred a growth advantage on the cells. Studies of Bcr-Abl transfected p53 null murine bone marrow and p53 null /Bcr-Abl transgenic mice also implicated p53 in the disease progression (Honda et al., 2000; Skorski et al., 1996) . p53 null cells transfected with Bcr-Abl displayed growth factor independence and were morphologically less dierentiated than their p53 expressing counterparts. In addition, immunode®cient mice injected with these cells developed a highly aggressive, poorly dierentiated acute myeloid leukaemia. Importantly, both Bcr-Abl and the loss of p53 were required for the development of the leukaemic like phenotype. A further reason to assess whether prolonged Bcr-Abl PTK expression in¯uences p53 levels is the apparent ability of p53 to induce dierentiation in K562 cells implicating p53 in the abnormal dierentiation features of acute phase CML (Feinstein et al., 1992; Kremenetskaya et al., 1997) .
Numerous attempts have been made to model CML using IL-3 dependent cell lines (Carlesso et al., 1994; Daley and Baltimore, 1988; Kabarowski et al., 1994; Klucher et al., 1998; Laneuville et al., 1992) . Although these systems show the oncogenic potential of Bcr-Abl, they do not address the complex pathogenesis of CML. They have limited value in de®ning the events that lead to blast crisis, since they display a phenotype similar to that of the blast crisis stage of CML. This illustrates the absolute necessity to express Bcr-Abl in a biological relevant context, that is a haemopoietic progenitor cell capable of myeloid dierentiation. Thus, to produce a biologically relevant and experimentally convenient model of CML to de®ne molecular mechanisms underlying the progression of primitive Ph + cells to blast crisis, we expressed a conditional mutant of BcrAbl in the primitive multipotent haemopoietic cell line, FDCP-Mix (Pierce et al., 1998a) .
We have previously reported that expression of BcrAbl PTK activity in the FDCP-Mix cells for up to 10 days did not alter their ability to dierentiate or their absolute requirement for growth factors to survive and proliferate (Pierce et al., 1998a) . However, in the absence of added growth factor the cells displayed increased survival. In limiting concentrations of growth factors the cells exhibited enhanced survival and proliferation. The tsBcr-Abl transfected FDCP-Mix cells were, thus, similar in many respects to Ph + progenitor cells during the initial chronic phase. They retained their ability to dierentiate into mature myeloid cells and also retained their absolute requirement for growth factors to survive and proliferate.
Here we report the eects of prolonged exposure to Bcr-Abl PTK on haemopoietic cell dierentiation and identify p53 modulation as a possible key molecular event associated with Bcr-Abl mediated progression in CML.
Results
Prolonged exposure to Bcr-Abl PTK activity results in the acquisition of Bcr-Abl dependent growth factor independence When FDCP-Mix tsBcr-Abl cells were maintained at the permissive temperature inde®nitely under conditions which did not positively select for clonal outgrowth of factor independent clones (i.e. high concentrations of IL-3) they were observed to become factor independent (Figure 1 ). After 9 ± 15 weeks culture the tsBcr-Abl FDCP-Mix cells cultured at the permissive temperature (328C) but not those maintained at the restrictive temperature (398C) could proliferate in the absence of IL-3 (Figure 1a ). The average time to onset of overt factor independent proliferation at 328C in the presence of IL-3 was 12 weeks (12+3 weeks, mean+s.d., n=7). This eect was dependent on the presence of an active BCR-ABL PTK because, as previously shown, the parental FDCP-Mix and FDCP-Mix neo cells do not give rise to factor independent cells (Just et al., 1991) . More importantly, when the factor independent tsBcr-Abl cells were transferred back to the restrictive temperature, growth factor dependence was restored ( Figure  1b) . FDCP-mix tsBcr-Abl clone 2 LT 398C, assay at 398C, FDCP-mix tsBcrAbl clone 2 LT 328C, assay at 328C.
FDCP-mix tsBcr-Abl clone 16 LT 398C, assay at 398C.
FDCP-mix tsBcr-Abl clone 16 LT 328C, assay at 328C. (b) Growth factor independent proliferation and its reversible nature. The proliferation rate of FDCP-Mix and tsBcr-Abl clones 2 and 16 maintained long-term at 328C or 398C was assessed by [3H]thymidine incorporation at both 328C and 398C in the absence of added IL-3. Data are expressed as a percentage of thymidine incorporation observed in maximally stimulating conditions (10 ng/ml of IL-3 with 10% HS) at the relevant assay temperature and is a representative experiment of three.
FDCP-mix control maintained LT at 398C prior to thymidine uptake.
FDCP-mix control maintained LT 328C prior to thymidine uptake.
FDCPmix tsBcr-Abl clone 2 maintained LT at 398C prior to thymidine uptake.
FDCP-mix tsBcr-Abl clone 2 maintained LT at 328C prior to thymidine uptake (capable of factor independent growth, see (a).
FDCP-mix tsBcr-Abl clone 16 maintained LT at 398C prior to thymdine uptake.
FDCP-mix tsBcr-Abl clone 16 maintained LT at 328C prior to thymidine uptake (capable of factor independent growth, see (a) When cells were plated at 398C in semi-solid media without IL-3 after prolonged culture at 328C no factor independent colonies grew, indicating that there is not a subset of cells which are factor-independent, regardless of BCR-ABL activity. All the experiments presented have been repeated with multiple clones of FDCP-Mix cells expressing tsBcr-Abl.
Recent reports indicating that Bcr-Abl mediated growth factor independence arises due to autocrine production of growth factors (Jiang et al., 1999) . However, we were unable to detect any IL-3, SCF or G-CSF production in the tsBcr-Abl FDCP-Mix cells using RT ± PCR (data not shown). It therefore appears that the observed growth factor independence does not arise due to the production of these cytokines.
Differentiation is delayed and cell morphology abnormal as a consequence of prolonged exposure to Bcr-Abl PTK activity CML is a progressive disease in which normal myeloid dierentiation is lost in accelerated phase and blast crisis. To see if this results from long-term exposure to Bcr-Abl PTK activity (as we have observed for cytokine independence) we tested the ability of tsBcrAbl FDCP-Mix cells to undergo myeloid cell dierentiation.
TsBcr (Figure 2k ,l). These cell types were scored as abnormal in the dierential morphology. Following 7 days in culture under myeloid dierentiation conditions the cells were unable to form colonies in soft gels in the presence of IL-3 (data not shown). The discordant development was, therefore, not associated with persistence of clonogenic cells under dierentiation conditions. Furthermore, control cells showed no such acquisition of a developmental abnormality and were unaected by prolonged exposure to culture at 328C (Figures 2g, j, m and 3a) . The data show very clearly that there is a consistent signi®cant dierence between panel (c) (maintained at 328C and dierentiated at 328C) and all other groups for the delayed development and abnormal morphology (see footnote to Figure 3 ). The other groups are not statistically dierent from one another. Despite their abnormal appearance, the neutrophils present were capable of phagocytosis (see Figure 2k ). Undierentiated FDCP-Mix cells were unable to phagocytose FITC conjugated latex beads. However, cells induced to undergo dierentiation were capable of phagocytosis, whether from cells cultured long-term at 398C or 328C and induced to dierentiate at 398C or 328C (data not shown).
The unusual development we observed was dependent on the long-term exposure to Bcr-Abl PTK and the continued presence of Bcr-Abl PTK during dierentiation. This is demonstrated by the reversion of the dierentiation to normal following long-term maintenance at the permissive temperature and dierentiation at the restrictive temperature (Figures 2n,o  and 3f ).
To con®rm the abnormal phenotype and/or delayed development we examined the expression of two cell surface markers (Gr-1 and Mac-1) associated with maturing and mature neutrophils and macrophages. Parental and tsBcr-Abl expressing cells were negative for Gr-1 and Mac 1 expression under culture conditions that promote self-renewal. As expected, when induced to dierentiate parental FDCP-Mix cells stained positively with GR-1 and Mac 1 antibodies. Mac 1 expression was positive though variable, in all the cells. Gr-1 expression was seen in subsets of the FDCP-Mix cells. Short-term exposure to Bcr-Abl PTK decreased the number of cells expressing both Gr-1 and Mac 1 (compare Figure  4a ,e,f). Growing tsBcr-Abl FDCP-Mix at the permissive temperature for 12 weeks and then allowing them to dierentiate at the restrictive temperature showed that the long-term exposure to Bcr-Abl had aected the ability of the cells to express Gr-1 and Mac 1 (compare Figure 4b,d,f) . This is probably due to the persistence of changes in the tsBcr-Abl FDCP-Mix cells after the switch back from permissive to restrictive temperature.
Most notable was the fact that Mac 1 expression was completely abrogated by growing and dierentiating tsBcr-Abl FDCP-Mix cells at the permissive temperature (compare Figure 4a,c) . Gr-1 expression was increased in these cells compared to nondierentiated cells, but the expression was much lower than seen when control FDCP-Mix were induced to dierentiate (a). Furthermore all the tsBcr-Abl cells exposed to Bcr-Abl chronically (c) expressed low levels of Gr-1, whereas in control samples (Figure 4a,b,f) two populations were present, those not expressing Gr-1 at all and those with relatively high levels of expression. It should be pointed out here that Figure  2k ,l shows quite clearly that cells from Figure 4c contain morphologically recognizable neutrophils and macrophages. Thus, mature cells which normally express Gr-1 and Mac-1 are not doing so as a direct consequence of Bcr-Abl PTK exposure. Surface phenotype and morphological status have been uncoupled by the Bcr-Abl oncogene. . Row 1 (a,b,c); 12 weeks or longer growth in conditions for maintenance of a primitive phenotype at 398C. Row 2 (d,e,f); maintained with a primitive phenotype at 398C and dierentiated for 10 days at 398C. Row 3 (g,h,i); maintained with a primitive phenotype at 328C for 12 weeks or longer. Row 4 (j,k,l); maintained with a primitive phenotype at 328C and dierentiated for 10 days at 328C, Row 5 (m,n,o); maintained with a primitive phenotype at 328C and dierentiated for 10 days at 398C. Magni®cation 62000
The onset of discordant development correlates with p53 modulation Alterations in p53 expression are implicated in CML disease progression. We therefore investigated the eects of prolonged exposure to Bcr-Abl PTK on p53. We observed a reduction in wtp53 levels during the emergence of the growth factor independence and discordant development in the FDCP-Mix tsBcr-Abl cells. The level of expression and the conformation of p53 was investigated using immunoprecipitation with a range of monoclonal antibodies. Four anti-p53 antibodies were used: Ab240, 248, 421 and Ab1620. In immunoprecipitation Ab240 recognizes only mutant p53, Ab248 and 421 are pan-speci®c, whilst Ab1620 recognize epitopes present in wtp53 alone. The parental and tsBcr-Abl cells at both 328C (18 h) and 398C were positive for the p53 epitopes 248, 421 and 1620 ( Figure  5a ). Failure to detect the 240 epitope suggests that the FDCP-Mix cells contain wtp53 in the presence of BcrAbl PTK activity. We also failed to detect any mutant p53 following prolonged exposure to Bcr-Abl PTK (Figure 5b ). However, there was a marked reduction in the amount of p53 detected with antibodies Ab248, 421 and Ab1620 (Figure 5b ). Western blotting con®rmed this decrease in p53 expression following prolonged exposure to Bcr-Abl PTK (Figure 5c ). Interestingly, when the cells with decreased levels of p53 were Students t-test analysis of dierential morphologies at day 10 of dierentiation. Bold font indicates the group in which Bcr-Abl PTK is active during both prior maintenance and dierentiaton of the cells Figure 3 Blasts and early granulocytes Mature granulocytes Monocytes Abnormal cells
Comparison of panels in
NS P40.05; *P50.05; **P50.01; ***P50.001
Oncogene Bcr-Abl induces abnormal haemopoietic differentiation A Pierce et al transferred back to the restrictive temperature, the p53 increased to levels observed in cells not exposed to BcrAbl PTK activity (Figure 5d ). Thus, as with the growth factor independence and altered dierentiation, the p53 Bcr-Abl induces abnormal haemopoietic differentiation A Pierce et al down regulation arising from prolonged exposure to Bcr-Abl PTK activity was reversible i.e. it was still reliant on Bcr-Abl PTK activity. It is important to emphasize that we never observed a complete loss of p53 protein expression. RNA analysis was undertaken to investigate whether or not the modulation of p53 protein occurred at the transcriptional or post-transcriptional level. This clearly demonstrated that there is no alteration in the levels of p53 RNA expression following prolonged exposure to Bcr-Abl PTK activity (data not shown) suggesting that the lower p53 levels occurs as a result of a decrease in p53 protein stability or translation. Similar observations with p53 protein stability have been made in AML where overexpression of Mdm-2 leading to increased degradation of p53 has been suggested to be the mechanism by which the cells escape p53 regulation (Seliger et al., 1996) . However, we saw no evidence of increased Mdm-2 expression in our system (data not shown).
Loss or inactivation of p53 results in delayed development in the presence of Bcr-Abl PTK activity
We have shown that there is a correlation between the loss of p53 and the acquisition of factor independence, abnormal and delayed development in multipotent cells. Can any of the eects be directly attributed to the loss of p53? We assessed this possibility in two ways, by using a p53 null FDCP-Mix cell line retrovirally transduced to express tsBcr-Abl and by expression of a dominant negative (DD) p53 in tsBcr-Abl FDCP-Mix cells. When the tsBcr-Abl PTK was activated in p53 null FDCP-Mix by switching the cells from the nonpermissive to the permissive temperature, there was no evidence of growth factor independence ( Figure 6 ). The shift to factor independence in the tsBcr-Abl FDCP-Mix grown at 328C for more than 12 weeks cannot, therefore, be solely due to the loss of p53 protein. Similarly, the expression of DDp53 did not aect the cytokine requirements of tsBcr-Abl FDCPMix cells when they were switched from the restrictive to the permissive temperature (data not shown). These two approaches show that p53 alone has no eect on cytokine requirement for proliferation in Bcr-Abl expressing multipotent cells.
We next considered the role of p53 in myeloid cell development. When the tsBcr-Abl, p53
null FDCP-Mix and control cells were cultured in dierentiation conditions at the permissive and restrictive temperatures for Bcr-Abl PTK activity we observed a profound delay in development of the tsBcr-Abl p53 null FDCPMix only when grown at the permissive temperature (Figure 7a ). After 7 days the cultures contained blast cells and primitive myeloid progenitor cells at about three times the level seen in the control cultures. After 10 days there were a few early myeloid progenitors present but the tsBcr-Abl p53 null FDCP-Mix cultures did not persist beyond 14 days. These data imply that the loss of p53 ( Figure 5 ) is causally related to the delayed development seen in tsBcr-Abl FDCP-Mix cells.
This was further con®rmed in the tsBcr-Abl FDCPMix DDp53 cells. When these cells were induced to undergo myeloid dierentiation at both the restrictive and permissive temperature we observed a delay in development at the permissive temperature for Bcr-Abl PTK activity (Figure 7b ). The inhibition of p53 action by the DDp53, therefore, recapitulates the delayed development observed as a consequence of long-term exposure to Bcr-Abl activity which is accompanied by a reduction of p53. The dierentiation delay resulting from DDp53 is greater than that observed in the LT tsBcr-Abl FDCP-Mix cells. This may be due to the fact we observe a reduction, but not complete loss of p53 in these cells ( Figure 5 ). We conclude that p53 loss is involved with the mechanisms that result in the delayed dierentiation in tsBcr-Abl FDCP-Mix cells exposed to Bcr-Abl PTK activity for 412 weeks. We did not observe morphologically abnormal cells (seen in the LT tsBcr-Abl cells dierentiated at the permissive temperature) in either the tsBcr-Abl, p53 null FDCP-Mix or tsBcr-Abl FDCPMix DDp53 above 2% of the total cell population.
Discussion
To identify the long-term consequences of Bcr-Abl PTK expression in primitive haemopoietic cells we have used a temperature sensitive kinase mutant of Bcr-Abl expressed in the multipotent haemopoietic FDCP-Mix cells. These cells represent a model system with appropriate biological characteristics to allow convenient, meaningful investigations into the molecular mechanisms of CML.
CML is a progressive disease and, although colony forming cells in chronic phase are factor dependent, this is less clearly the case in blast crisis where the dependency on exogenous stimuli is decreased (MaguerSatta et al., 1998; Metcalf et al., 1974) . In keeping with this, following an average of 12 weeks exposure to Bcr-Abl PTK activity, growth factor independent tsBcr-Abl FDCP-Mix cells became evident. This phenomenon has been previously reported by Kabarowski et al. (1994) in the lymphoid cell line Ba/F3. The growth factor independence was still dependent upon Bcr-Abl activity. When the tsBcr-Abl FDCP-Mix cells were placed at the restrictive temperature growth factor dependence was restored. Our observations support the suggestion that, in the progression of the growth factor dependence to independence, the FDCP-Mix Bcr-Abl cells may be following similar molecular mechanisms that occur in the progression of CML.
In view of the nature of CML, far more important was the fact that the cells maintained at the permissive temperature for many weeks lost the ability to undergo dierentiation at the rate normally observed in FDCPMix cells. Furthermore, there was not only developmental retardation but also acquisition of atypical neutrophil morphology in the cells that did dierentiate. Hyposegmentation was one atypical feature observed that has previously been reported as being associated with CML accelerated phase in some patients (Williams, 1995) .
The Bcr-Abl induced aberrant development was also accompanied by abnormalities in Gr-1 and Mac-1 expression during maturation. Both short-term and chronic exposure to Bcr-Abl activity inhibits Gr-1 expression (Gr-1 is a protein of unknown function expressed during granulocytic dierentiation (Fleming et al., 1993) ).
Chronic exposure to Bcr-Abl PTK also totally abrogates the ability of dierentiating FDCP-Mix cells to express Mac 1, an eect which is partially reversible by allowing the tsBcr-Abl FDCP-Mix cells to dierentiate at the permissive temperature. When FDCPMix cells are only exposed to Bcr-Abl PTK activity during dierentiation there is also inhibition of Mac 1 expression. Mac 1 (known as CD11b, aM b 2 integrin and complement receptor 3) is expressed on macrophages and granulocytes, and mediates adherence via a receptor function for ICAM-1 and ®brinogen (Leenen et al., 1994; Lub et al., 1996) . Pedersen (1982) has noted that CML neutrophils display subnormal adhesiveness and delayed emigration to extravascular sites. It is possible that Bcr-Abl mediated changes in the expression and activation of integrins accounts for such observations, our data with FDCP-Mix cells supports this.
More importantly, the morphological data with the expression pro®les for Mac 1/Gr-1 indicate that the nuclear morphological maturation of FDCP-Mix cells and expression of cell surface maturation markers is discordant. This resonates with the theories of Strife and Clarkson (1998) who stated in their seminal review paper`altered tyrosine kinase activity of the P210 Bcr-Abl protein, or some other biochemical alteration associated with the t(9;22) translocation, causes a subtle garbling in the transmission of regulatory messages null FDCPMix (a) and DDp53 tsBcr-Abl FDCP-Mix (b) cells were subject to myeloid dierentiation as described for Figure 3 . The histogram legend is as shown in Figure 3 . Results shown are the mean+s.e.m. of three experiments and were subject to a twotailed paired t-test. In (a) the percentage blasts at 7 days were compared between control and tsBcr-Abl at both temperatures and tsBcr-Abl at 328C and 398C. In (b) the percentage blasts at 7 days were compared between control and DDp53 at both temperatures and DDp53 at 328C and 398C. **Indicates a value for P of less than 0.01 through the transduction pathways, with the result that the leukemic stem cells' normal sequence of maturation is distorted so that the cytoplasmic and nuclear maturation proceeds asynchronously'. The data we present supports such a theory by showing, in a model system, that Bcr-Abl directly aects development and in some cells leads to discordance in the expression of surface markers compared to nuclear morphology.
The fact that this aberrant dierentiation depends on the continued presence of tsBcr-Abl PTK activity is important: it indicates that persistent activation of BcrAbl is essential to drive signi®cant changes in the ability of these cells to develop normally. This, plus the observation that Ph + cells in blast crisis require less cytokine stimulation, as do tsBcr-Abl FDCP-Mix cells at 328C, shows that we have, in part, mimicked the progression of CML into accelerated phase.
p53 has a key role in sensing DNA damage and cell cycle regulation (for review see Levine, 1997) whilst also being involved in the regulation of dierentiation (Amariglio et al., 1997; Sabapathy et al., 1997; Shounan et al., 1996; Soddu et al., 1996) . Alterations in p53 expression are heavily implicated in CML disease progression (see Introduction). This is not only due to the appearance of structural alterations in blast crisis (Ahuja et al., 1989; Mashal et al., 1990; Prokocimer and Rotter, 1994) but also observations on the eects of reduced wtp53 levels and the ability of p53 to induce dierentiation in the CML blast crisis cell line K562.
During the emergence of the growth factor independence and discordant development in the FDCP-Mix tsBcr-Abl cells we observed a reduction in wtp53 levels. These data support a role for reduced p53 levels in disease progression. The altered regulation of p53 expression was not due to mutation, as it was reversible, and the Bcr-Abl PTK did not alter the transcription rate of p53.
The experiments with the dominant negative p53 and p53 null tsBcr-Abl FDCP-Mix cells con®rm that the reduction in p53 alone is not the cause of changes in the cytokine requirements or the abnormal development in the LT tsBcr/Abl FDCP-Mix cells. However, reduction of p53 does combine with Bcr-Abl activity to retard neutrophil/macrophage development.
These ®ndings con®rm the study by Skorski et al. (1996) . p53 null cells transfected with Bcr-Abl were morphologically less dierentiated than their p53 expressing counterparts. Here, too, both Bcr-Abl and the loss of p53 were required for the development of the leukaemic like phenotype. Our observations further those of Skorski in that they not only implicate p53 in disease progression but also imply a role for Bcr-Abl in the control of p53 protein stability. There is a precedent for this, Bcr-Abl has previously been shown to be involved in the regulation of protein turnover for the Abi proteins, a family of Abl interacting proteins (Dai et al., 1998) . These observations are of particular interest since JNK has been implicated in the regulation of p53 protein stability (Fuchs et al., 1998a,b) and is known to be activated by Bcr-Abl and in CML patient samples (Burgess et al., 1998; Raitano et al., 1995) .
The decrease in p53 may not only lead to altered developmental rates but also predispose the cells to further mutations. Inactivation of p53 increases the rate of homologous recombination (Mekeel et al., 1997; Sturzbecher et al., 1996) , an important event in chromosomal translocations, providing a link between p53 and increased genetic instability in the late stages of tumorigenesis.
Whilst only 25 ± 30% of patients in blast crisis are reported to have alterations in p53 expression, the eects we observed in this model, i.e. a reduction in p53 protein levels are much harder to quantify and would not have been detected in the vast majority of studies to date which have concentrated on the appearance of p53 mutations. Since a simple reduction in p53 gene dosage is now being recognized as a possible factor in tumorigenesis of many other tissues (Venkatachalam et al., 1998) we propose that the reduction in p53 expression as well as (or preceding) mutations to p53 may be an important contributor to the progression of CML from the chronic to blast crisis.
Given the fact that long-term exposure to Bcr-Abl PTK activity induces a loss of p53, a delay in development and dysplastic granulocyte production, we believe that, in part, we are recapitulating the accelerated phase of CML. The modelling of CML in the FDCP-Mix multipotent cell line oers the opportunity to identify the initial molecular events leading to the phenotypic, pathology-related changes seen in multipotent haemopoietic cells expressing an activated Bcr-Abl PTK.
We are currently attempting to assess p53 protein levels in progenitor cells from patients with CML at presentation and in accelerated phase and to compare these with normal progenitor cell populations. In this way the signi®cance of our results to CML can be established.
Materials and methods

Maintenance and differentiation of FDCP-Mix Cells
FDCP-Mix A4 cells were maintained in Fischers medium supplemented with pre-selected batches of horse serum (20% v/v) and IL-3. The cells were subcultured twice a week to a cell concentration of 6 ± 8610 4 cells/ml and maintained at 328C or 398C in 5% CO 2 in air. In these culture conditions the FDCP-Mix maintain a primitive blast cell phenotype. p53 null multipotent FDCP-Mix cells were generated from the bone marrow of p53 null mice using long-term marrow cultures as previously described (Spooncer et al., 1986) . Cells were induced to undergo myeloid dierentiation by culture in Iscoves Modi®ed Dulbeccos Medium supplemented with foetal calf serum (20% v/v), recombinant (r) murine GM-CSF (50 U/ml), r-human G-CSF (3000 U/ml) and r-murine IL-3 (0.1 ng/ml) as previously described (Pierce et al., 1998b) .
Retroviral transfection
FDCP-Mix A4 and p53
null FDCP-Mix cells were transfected with the retroviral vector pM5-neo or pM5-neo carrying a p210 tsBcr-Abl cDNA as described by Pierce et al. (1998a) . The p210 tsBcr-Abl cDNA encodes for a temperature sensitive kinase mutant of p210 Bcr-Abl. Expression is unaected by temperature but its tyrosine kinase activity is present at 328C (permissive) and inactive at 398C (restrictive temperature). TsBcr-Abl FDCP-Mix A4 cells were transfected with the retroviral vector pM5-hygro or pM5-hygro carrying a truncated p53 which acts as a dominant negative inhibitor (DD) of p53 function. The DDp53 cDNA was constructed by site directed mutagenesis as described by Shaulian et al. (1992) . Expression is unaected by temperature. Experiments were performed using at least two dierent clones of the tsBcr-Abl FDCP-Mix cells.
Western blotting and immunoprecipitation
Western blotting and immunoprecipitation were carried out as previously described (Spooncer et al., 1994) . The expression of p53 was analysed by Western blotting using a polyclonal antibody to p53 (a gift from T Hupp, Dundee). To investigate p53 conformation the antibodies Ab240, 421, 1620 (Oncogene Science) and Ab248 (a gift from T Hupp, Dundee) were used for immunoprecipitation.
Measurement of DNA synthesis
DNA synthesis was measured using a [ 3 H]thymidine incorporation assay as previously described (Pierce et al., 1998b) .
Northern blotting
RNA extracts were prepared with TRIzol reagent (Gibco BRL, Paisley, UK). Northern blotting was undertaken with radiolabelled probes by standard techniques (Sambrook et al., 1989) .
Flow cytometry
Flow cytometry analysis was performed using a Becton Dickinson FacsVantage instrument. Cells expressing Gr-1 and Mac 1 were identi®ed as previously described in Evans et al. (1999) .
